Analyis of changes in the serum concentration of cystatin c, creatinine and renal neutrophil gelatinase-associated lipocalin in patients with hemorrhagic fever with renal syndrome
https://doi.org/10.22625/2072-6732-2015-7-3-64-71
Abstract
Introduction. Acute kidney injury is a frequent complication of hemorrhagic fever with renal syndrome. The objective evaluation of аcute kidney injury severity degree is significant in determining the amount of medical actions at hemorrhagic fever with renal syndrome.
Objective. Тhe shifts of acute kidney injury biomarkers’ levels (urine neutrophil gelatinase-associated lipocalin, serum cystatin C and serum creatinine) at different periods of hemorrhagic fever with renal syndrome were evaluated.
Methods. Depending to hemorrhagic fever with renal syndrome severity the patients were divided into groups with severe (n=16) and moderate form of hemorrhagic fever with renal syndrome (n=10); the control group included 10 healthy individuals. The levels of biomarkers were measured by ELISA.
Results. Тhe serum concentration of creatinine and cystatin C – markers of glomerular pathology – increased significantly in hemorrhagic fever with renal syndrome, peaking at oligouric period; while changes of cystatin C were more rapid. Urine neutrophil gelatinase-associated lipocalin level – marker of renal tubular damage – increased 30 to 96 times compared to the control group in fever period of hemorrhagic fever with renal syndrome and gradually decreased thereafter.
Conclusion. Тhe use of modern biochemical markers of renal pathology (sCystatin C, urine neutrophil gelatinaseassociated lipocalin) in hemorrhagic fever with renal syndrome, along with traditional indicators, allows a more differentiated approach to the assessment of renal pathology and gives additional evidence to highlight stage and severity of the disease.
About the Authors
E. M. MingazovaRussian Federation
D. A. Valishin
Russian Federation
A. Z. Gilmanov
Russian Federation
L. R. Shajhullina
Russian Federation
References
1. Sirotin B. Z. Gemorragicheskaja lihoradka s pochechnym sindromom / B. Z. Sirotin. – Habarovsk, 1994. – 300 s.
2. Onishhenko G. G., Tkachenko E. A. Sovremennoe sostojanie gemorragicheskoj lihoradki s pochechnym sindromom / E. A. Tkachenko, G. G. Onishhenko // Materialy Vseros. nauchno-praktich. konf. «Gemorragicheskaja lihoradka s pochechnym sindromom: istorija izuchenija i sovremennoe sostojanie jepidemiologii, patogeneza, diagnostiki, lechenija i profilaktiki». – Ufa, 2006. – S. 4-14.
3. Lisowska – Myjak B. Serum and urinary biomarkers of acute kidney injury. Blood. Purif. 2010 Jan; 29 ( 4): 357 – 365.
4. Trof R. J., Di Maggio F., Leemreis J., et al. Biomarkers of acute renal injury and renal failure. Shock 2006 Sep; 26 ( 3): 245-253.
5. Pokrovskij V. M. Vydelitel’naja sistema / V. M. Pokrovskij, Korot’ko G. F. // Fiziologija cheloveka: uchebnik dlja studentov medvuzov 2-e izd., dop. i pererab. – M.: Medicina, 2003. – Ch. 2., gl. 12. – S. 450-552.
6. Smirnov A. V. Problema ocenki skorosti klubochkovoj fil’tracii v sovremennoj nefrologii: novyj indikator – cistatin S / A. V. Smirnov, I. G Kajukov // Nefrologija. – 2005. – №3. – C.16-27.
7. Nejat M., Pickering J. W., Walker R. J., et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol. Dial. Transplant. 2010; 25: 3283 – 3289.
8. Instrukcija po primeneniju nabora reagentov dlja immunofermentnyh analizov in vitro «NGAL bystryj IFA test» (NGAL Rapid ELISA Kit) proizvodstva BioPorto Diagnostics A/S, Danija.
9. Sachin S. S., Dinna C., Bobek I., Chang Y. C., et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. International Urology and Nephrology. 2010 March; 42 (1): 141-150.
10. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark. Med. 2010 Jan; 4 (2): 265-280.
11. Doi K., Katagiri D., Negishi K. Mild elevation of urinary biomarkers in prerenal acute kidney. Kidney Int. 2012; 82: 1114-20.
12. Lattanzio M. R., Nelson P. Acute Kidney Injury: New concepts in definition, diagnosis, pathophysiology and treatment. JAOA. 2009; 109 ( 1): 13-19.
13. Yong G., Kui-Po Y. Prognostic significance of urine neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury Urinary biomarkers in septic acute kidney injury. Experimental and Therapeutic Medicine. 2011 Aug; 2 (6): 1133-1139.
14. Haase-Fielitz A., Bellomo R., Devarajan P., et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrology Dialysis Transplantation. 2009; 24 (11): 3349–3354.
Review
For citations:
Mingazova E.M., Valishin D.A., Gilmanov A.Z., Shajhullina L.R. Analyis of changes in the serum concentration of cystatin c, creatinine and renal neutrophil gelatinase-associated lipocalin in patients with hemorrhagic fever with renal syndrome. Journal Infectology. 2015;7(3):64-71. (In Russ.) https://doi.org/10.22625/2072-6732-2015-7-3-64-71